Perfalgan use in children

The licence for perfalgan (paracetamol) has been extended to include the use in infants and neonates.

Perfalgan is administrated at a dose of 7.5mg/kg up to four times a day by intravenous infusion over 15 minutes in children weighing less than 10kg. The minimum interval between each administration must be four hours and the maximum daily dose must not exceed 30mg/kg.

Further information: BMS 01895 523000

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Two new steroid inhalers launched

Two new steroid inhalers launched

A new beclometasone metered-dose inhaler and a new...

Half of patients on statins do not reach cholesterol goals, study shows

Half of patients on statins do not reach cholesterol goals, study shows

Half of patients prescribed statins fail to reach their...

First oral hypoglycaemic licensed for add-on therapy in type I diabetes

First oral hypoglycaemic licensed for add-on therapy in type I diabetes

The SGLT2 inhibitor dapagliflozin (Forxiga) can now...

Quick-reference MIMS COPD prescribing resources updated

Quick-reference MIMS COPD prescribing resources updated

Concise MIMS resources on COPD management and antibiotic...